A new clinical case confirms the efficacy of MLS® for treating Covid-19 pneumonia

12 October 2021 - Research

New studies and clinical reports confirm that MLS® Laser Therapy is useful for contributing to the treatment of patients with COVID-19 pneumonia.

Used as a complementary treatment to standard drug therapy, MLS® alleviates acute inflammatory events caused by an excessive production of pro-inflammatory cytokines and favours pulmonary functional recovery.

This is confirmed by a recent clinical case concerning a 70-year old patient admitted to hospital with symptoms of respiratory failure, cough, vomiting and chest pain, with X-ray evidence of atypical pneumonia from COVID-19. The patient underwent drug therapy combined with a daily session of MLS® Laser Therapy for 5 days and showed:

  • a significant increase in the level of oxygen saturation, which went from the initial 90% to 98%;
  • a general improvement of his health with a regression of symptoms;
  •  significant decrease of the level of ferritin, recognised as a marker of acute and chronic inflammation.
Chest X-rays before MLS
Chest X-rays after MLS

The chest X-ray carried out both before and after the laser therapy with the M6 device furthermore showed a significant reduction in inflammation (clear and extended lungs, with a decrease in consolidations and opacities).  Although concerning one patient only, the results of the study support the use of MLS® Laser Therapy as an aid to manage patients with interstitial pneumonia.

Testo a Destra
Immagine 30%/Testo 60%

“Use of the MLS® Laser Therapy in the management of SARS-CoV-2 infection: a case report”
L. Cibulka, V. Petrtýlová
Energy For Health [21], 2021

READ MORE

You might also be interested in ...

See all articles

Energy for Health - Scientific review by ASAcampus
news - 01/10/2021
Energy for Health #21: MLS® at the forefront
Four case reports dedicated to applying the MLS® therapy, two in the human field and two in the veterinary field are the focus of the new edition of Energy for Health.
M8 laser treatment for pain due to COVID-19
blog - 09/04/2021
Journal Of Inflammation Research: MLS® Laser Therapy and the consequences of interstitial pneumonia caused by COVID-19
The results actually showed that patients undergoing MLS® Laser Therapy had a rapid recovery
press - 01/09/2020
NBC Boston News: MLS® treats a Covid-19 patient effectively
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for TMD
Blog - 22/10/2025
When research meets clinical practice: MLS® laser therapy in the treatment of myofascial pain from bruxism
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
M-Hi & HIRO TT Tour: Training for UK Professionals
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Effectiveness of laser therapy in treating some side effects of radiation and chemotherapy
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.